Venus Concept (NASDAQ:VERO) Shares Down 2.3% – Here’s What Happened

Venus Concept Inc. (NASDAQ:VERO)’s stock price dropped 2.3% during mid-day trading on Tuesday . The stock traded as low as $2.06 and last traded at $2.14. Approximately 34,293 shares traded hands during trading, a decline of 83% from the average daily volume of 205,508 shares. The stock had previously closed at $2.19.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Venus Concept in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Venus Concept Stock Down 2.3%

The company has a 50-day moving average of $2.32 and a 200-day moving average of $2.46. The company has a market capitalization of $3.04 million, a price-to-earnings ratio of -0.04 and a beta of 0.05. The company has a current ratio of 1.10, a quick ratio of 0.71 and a debt-to-equity ratio of 5.72.

Venus Concept (NASDAQ:VERO) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($8.03) earnings per share for the quarter, beating the consensus estimate of ($9.72) by $1.69. The business had revenue of $15.69 million for the quarter, compared to the consensus estimate of $14.01 million. Venus Concept had a negative return on equity of 871.77% and a negative net margin of 68.77%.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.